Perioperative Copeptin: Predictive Value and Risk Stratification in Patients Undergoing Major Surgery

NCT02687776 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 517

Last updated 2024-04-24

No results posted yet for this study

Summary

Observational cohort study examining the perioperative course of copeptin in patients undergoing elevated-risk surgery.

Conditions

  • Perioperative Myocardial Injury

Sponsors & Collaborators

  • Heinrich-Heine University, Duesseldorf

    collaborator OTHER
  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Giovanna Lurati Buse, MD, MSc · Heinrich Heine University Dusseldorf

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2021-12-10
Completion
2021-12-10

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02687776 on ClinicalTrials.gov